Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pharvaris N.V.
(NQ:
PHVS
)
16.90
-1.38 (-7.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pharvaris N.V.
< Previous
1
2
3
4
5
Next >
Shopify (SHOP) Stock Falls Following Analyst Downgrade
December 06, 2023
Shopify stock is taking a beating on Wednesday after shares of SHOP were hit with a downgrade from Wedbush analyst Scott Devitt.
Via
InvestorPlace
Why Is Pharvaris (PHVS) Stock Up 36% Today?
December 06, 2023
Pharvaris stock is rising higher on Wednesday following news of an underwritten offering for PHVS shares and pre-funded warrants.
Via
InvestorPlace
US Stocks Higher; Private Payrolls Rise By 103,000 In November
December 06, 2023
U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28%...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pharvaris Announces Pricing of $300 Million Underwritten Offering of Ordinary Shares and Pre-funded Warrants
December 06, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
8 Analysts Have This to Say About Pharvaris
August 15, 2023
Via
Benzinga
Analyst Expectations for Pharvaris's Future
July 17, 2023
Via
Benzinga
Why Shares of Pharvaris N.V. Are Up Tuesday
June 27, 2023
Promising news from the Food and Drug Administration spurred the healthcare stock's rise.
Via
The Motley Fool
Pharvaris Announces Positive Top-line Phase 2 Data from the CHAPTER-1 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks
December 06, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
Pharvaris to Present at the GA²LEN UCARE Conference 2023
November 30, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
Pharvaris Appoints Stefan Abele, Ph.D., as Chief Technical Operations Officer
November 15, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
5 Analysts Have This to Say About Pharvaris
June 26, 2023
Via
Benzinga
Pharvaris Presents Deucrictibant Clinical Data and Real-World HAE Treatment Satisfaction Data at ACAAI 2023 Annual Scientific Meeting
November 09, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
Pharvaris Reports Third Quarter 2023 Financial Results and Provides Business Update
November 02, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
Pharvaris To Present at the ACAAI 2023 Annual Scientific Meeting
October 30, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
Pharvaris To Present at the APAAACI 2023 International Conference
October 13, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
Pharvaris To Present at the CIIC Fall 2023 Conference
October 04, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
Pharvaris' Promising Oral Treatment Solutions For Treating Swollen Blood Vessels - Analyst Sees 35% Upside
September 25, 2023
Wedbush has initiated coverage on Pharvaris N.V. (NASDAQ: PHVS), noting that the company stands out as one of the players with their strategy to develop and advance oral therapeutic options in both the...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
September 25, 2023
Via
Benzinga
Pharvaris To Participate in the 2023 Cantor Global Healthcare Conference
September 19, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
Smucker, FuelCell Energy, Granite Ridge Resources And Other Big Stocks Moving Lower On Monday
September 11, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording losses in today’s session. IHS Holding Limited (NYSE: IHS) shares fell 15.7% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pharvaris To Present at the 18th German Allergy Congress
September 06, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
Pharvaris To Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
Pharvaris To Present at the 2023 HAEi Regional Conference EMEA
August 23, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
Farfetch, Faraday Future Intelligent Electric, VinFast, And Other Stocks Moving Lower On Friday
August 18, 2023
U.S. stocks traded down this morning, with the Nasdaq Composite falling more than 101 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 15, 2023
Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
August 15, 2023
Via
Benzinga
Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday
August 15, 2023
U.S. stocks traded lower, with the Dow Jones falling around 300 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pharvaris Reports Second Quarter 2023 Financial Results and Provides Business Update
August 07, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
Pharvaris Presents Clinical Data at the 2023 U.S. HAEA National Summit
July 21, 2023
From
Pharvaris N.V.
Via
GlobeNewswire
FDA Removes Clinical Hold Of Pharvaris' Deucrictibant For On-Demand Treatment Of HAE
June 26, 2023
Pharvaris NV (NASDAQ: PHVS) announced that the FDA lifted the clinical hold on the Investigational New Drug (IND) application for deucrictibant (PHA-121) for the on-demand
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.